期刊文献+

儿童急性白血病微小残留病检测方法与评价 被引量:1

Assays of the minimal residual disease in pediatric acute leukemia
原文传递
导出
摘要 白血病的微小残留病常成为白血病复发的根源,定量检测微小残留病对指导临床治疗具有重要意义.目前常用的定量检测方法有三种,包括检测异常抗原表型的流式细胞技术、抗原受体基因重排的PCR扩增技术、融合基因的PCR扩增技术.每种方法原理及特点不同导致I临床应用范围不同.根据患者自身特点,选择合适的检测方法,能使微小残留病定量更准确. Minimal residual disease(MRD)iS the origin of relapse in leukemia.So it's significant to quantitate MRD in clinical.At present, there are three MRD quantitative assays, such as flow cytometric detection of abnormal immuno-phenotype,polymerase chain reaction(PCR)amplification of antigenreceptor genes and fusion transcripts.Because every measure has its own principle and feature.the clinical applications are different.Selecting suitable assays based on the characteristic of patients can help to quantitate MRD exactly.
出处 《国际儿科学杂志》 2011年第3期229-231,共3页 International Journal of Pediatrics
关键词 急性白血病 微小残留病 流式细胞术 PCR Acute leukemia Minimal residual disease Flow cytometry Polymerase chain reaction
  • 相关文献

参考文献19

  • 1Irving J, Jesson J, Virgo P, et al. Establishment and validation of a standard protocol for the deteetion of minimal residual disease in B lineage childhood acute lymphoblastie leukemia by flow cytometry in a multi-center setting. Haematologica,2009,94 (6) :870-874.
  • 2Campana D. Status of minimal residual disease testing in childhood haematological malignancies. Br J Haematol,2008 ,143 (4) :481-489.
  • 3Janossy G, Bollum FJ, Bradstock KF, et al. Cellular phenotypes of normal and leukemic hemopoietic cells determined by analysis with selected antibody combinations. Blood, 1980,56( 3 ) :430-441.
  • 4徐翀,赵惠君,吴政宏,薛惠良,汤静燕,陈静,潘慈,李莉,顾龙君,沈立松.流式细胞术检测儿童B细胞急性淋巴细胞白血病微小残留病[J].中华血液学杂志,2003,24(6):295-299. 被引量:29
  • 5Freeman SD, Jovanovic JV, Grimwade D. Development of minimal residual disease directed therapy in acute myeloid leukemia. Semin Oncol,2008,35 (4) :388-400.
  • 6Bjorklund E, Mazur J,Soderhall S, et al. Flow cytometric follow-up of minimal residual disease in bone marrow gives prognostic information in children with acute lymphoblastic leukemia. Leukemia, 2003,17 ( 1 ) : 138-148.
  • 7Borowitz MJ, Devidas M, Hunger SP, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors. A Children' s Oncology Group Study. Blood ,2008,111 ( 12 ) :5477-5485.
  • 8Kerst G, Kreyenberg H, Roth C, et al. Concurrent detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukaemia by flow cytometry and real-time PCR. Br J Haematol,2005,128 (6): 774-782.
  • 9Kern W, Haferlach C, Haferlach T, et al. Monitoring of minimal residual disease in acute myeloid leukemia. Cancer,2008,112( 1 ) :4- 16.
  • 10Bustin SA. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endoceinol, 2000,25 ( 2 ) : 169-193.

共引文献28

同被引文献17

  • 1Mullighan CG. Molecular genetics of B-precursor acute lymphoblastic leukemia[J]. J Clin Invest, 2012, 122(10): 3407-3415.
  • 2Patkar N, Alex AA, Ahmed R, et al. Standardizing minimal residual disease by flow cytometry for precursor B lineage acute lymphoblastic leukemia in a developing country[J]. Cytometry B Clin Cytom, 2012, 82(4): 252-258.
  • 3Liu Q, Wang M, Hu Y, et al. Significance of CD71 expression by flow cytometry in diagnosis of acute leukemia[J]. Leuk Lymphoma, 2014, 55(4): 892-898.
  • 4Lee RV, Braylan RC, Rimsza LM. CD58 expression decreases as nonmalignant B cells mature inbone marrow and is frequently overexpressed in adult and pediatric precursor B cell acute lymphoblastic leukemia[J]. Am J Clin Pathol, 2005, 123(1): 119-124.
  • 5Garand R, Beldjord K, Cave H, et al. Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL[J]. Leukemia, 2013, 27(2): 370-376.
  • 6Gaipa G, Basso G, Biondi A, et al. Detection of minimal residual disease in pediatric acute lymphoblastic leukemia[J]. Cytometry B Clin Cytom, 2013, 84(6):359-369.
  • 7Lutz C, Woll PS, Hall G, et al. Quiescent leukemic cells account for minimal residual disease in children lymphoblastic leukemia[J]. Leukemia, 2013, 27(5): 1204-1207.
  • 8Zhao XS, Liu YR, Zhu HH, et al. Monitoring MRD with flow cytometry: an effective method to predict relapse for ALL patients after allogeneic hematopoietic stem cell transplantation[J]. Ann Hematol, 2012, 91(2): 183-192.
  • 9Comerci CJ, Mace EM, Banerjee PP. CD2 promotes human natural killer cell membrane nanotube formation[J]. PLoS One, 2012, 7(10): e47664.
  • 10Nina F, Lars P, Ryder, et al. Identification of residual leukemic cells by flow cytometry in childhood B-cell precursor acute lymphoblastic leukemia: verification of leukemic state by flow-sorting and molecular/cytogenetic methords[J]. Haematologica, 2012, 97(1): 137-141.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部